z-logo
open-access-imgOpen Access
Frequency of Pulmonary Aspergillosis Among Clinically Suspected and Under Treatment Tuberculosis Patients , Khartoum State , Sudan
Author(s) -
Abubaker Agbash Baraka,
Salma Ali Alabid,
Mohammed Abdulgadir Mohammed,
Nagla Mohammed Ahmed
Publication year - 2021
Publication title -
maǧallaẗ kulliyaẗ ṭibb al-kanadī
Language(s) - English
Resource type - Journals
eISSN - 2521-4365
pISSN - 1810-9543
DOI - 10.47723/kcmj.v17i3.430
Subject(s) - medicine , tuberculosis , aspergillus fumigatus , aspergillosis , sputum , asymptomatic , aspergillus , chocolate agar , gastroenterology , surgery , agar plate , immunology , microbiology and biotechnology , pathology , biology , bacteria , genetics
Background Respiratory tract aspergillosis is a pulmonary disease cause by aspergillus species which are opportunistic fungi that mainly infect immuno-compromised patients .  Objective(s) The present study aimed to detect the frequency of pulmonary aspergillosis among clinically suspected and under follow up tuberculosis patients conducted at Tropical Diseases Teaching Hospital, Omdurman, Khartoum State , Sudan during the period from December 2019 to November 2020.  Materials and Methods One hundred and fifty sputum samples were collected from suspected cases of pulmonary tuberculosis and under follow up tuberculosis patients. All specimens were examined using 20% KOH and cultured on two sets of Sabouraudʹs Dextrose agar slope media with chloramphenicol. Results Asperigillus species were isolated from 9/150 (6%) patients. They represented 5(3.3%) A.fumigatus, 3 (2%) A. niger and 1 (0.6%) A. Flavus. It was found that all Aspergillus isolates were revealed from Non acid fast bacilli (Non AFB) patients 9/137(6.6%) with the most common frequency among asymptomatic patients 3/35(8.6%) , patients who were under tuberculosis treatment (8.5%), those who were under Rifampicin (RIF) and Isonizide (INH) treatment (10%) and with duration of less than three month. Also the higher percentage (13%) was represented among the age group range from 61-80 year and slightly among males 6/97 (6.2 %) than females 3/53 (5.7%). There was statistically non-significant association between the frequency of aspergillosis and the studied variables in this study. Conclusion  The frequency of pulmonary aspergillosis among patients with anti-tuberculosis treatment reflects the need for routine screening and diagnosis of those patients since the use of anti- tuberculosis treatment can promote the growth and reproduction of fungi. Keywords Pulmonary aspergillosis, tuberculosis, follow up patients. 

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here